Enhancement of perioperative tissue perfusion as a therapeutic strategy for major surgery.

Multiple organ dysfunction syndrome (MODS) accounts for most surgical deaths which occur some days postoperatively. Current hypotheses concerning the pathophysiology of MODS place tissue hypoxia and reperfusion as a central feature of the initiation and continuation of the syndrome. Surgical patients are at risk of developing overt and covert tissue hypoxia and hypoperfusion due to anesthetic, surgical, and other factors; and it is known that surgical patients with poor cardiovascular reserve have a worse outcome postoperatively. A number of clinical studies have attempted to intervene early in surgical patients to prophylactically improve tissue perfusion in the perioperative period by augmentation of cardiac output. These studies demonstrate a reduction in mortality and morbidity in these groups of patients. A similar approach has been tried in other groups of critically ill patients, at a later state in the evolution of their illness; these studies have not shown any improvement in outcome. In surgical patients, data show that those with more coexisting pathology and worse cardiac function may benefit most from a treatment approach aimed at improving tissue perfusion; furthermore, this may result in cost savings. The implications for the management of the higher risk surgical patient are obvious. It may no longer be acceptable to undertake surgery in these patients without facilities to monitor and improve cardiac output and tissue perfusion.